Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation.
Xiao T, Cui M, Zheng C, Wang M, Sun R, Gao D, Bao J, Ren S, Yang B, Lin J, Li X, Li D, Yang C, Zhou H.
Xiao T, et al. Among authors: yang c, yang b.
Front Pharmacol. 2021 Jun 17;12:669642. doi: 10.3389/fphar.2021.669642. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34220507
Free PMC article.